XLRM
XLR Medical Corp. [XLRM] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
XLRM Stock Summary
In the News
XLRM Financial details
Company Rating
-
Market Cap
0
Income
-1.65M
Revenue
2.16M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
-5.78
Forward P/E
-
PEG
0.47
P/S
-
P/B
-0.85
P/C
-
P/FCF
-
Quick Ratio
0.01
Current Ratio
0.01
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.3
EPS next Y
-
EPS next Q
-
EPS this Y
-116.03%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
178.37%
-
-
-
-
SMA20
-1.94%
SMA50
-29.37%
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-1036%
ROE
16%
ROC
0.13%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.23-1.4
52W High
0%
52W Low
0%
RSI
34.12
Rel Volume
3.12
Avg Volume
1.64K
Volume
5.1K
Perf Week
-0.99%
Perf Month
-1.96%
Perf Quarter
-
Perf Half Y
-27.01%
-
-
-
-
Beta
-7.68859
-
-
Volatility
0%, 0.03%
Prev Close
0%
Price
1
Change
0%
Company Profile
- Volume Average 1.64K
- CEO Mr. Michael Hill
- Headquarters Long Beach,NY,US
- IPO Date 2022-01-31
XLR Medical Corp. does not have significant operations. Previously, the company was engaged in developing a cancer treatment technology. It intends to seek business opportunities by entering into a business transaction. The company was founded in 2000 and is based in Long Beach, New York.
